Status:
COMPLETED
The Impact of Abdominal Body Contouring Surgery on Physical Function After a Massive Weight Loss (BCSP)
Lead Sponsor:
University of British Columbia
Conditions:
Weight Loss
Obesity
Eligibility:
All Genders
18-65 years
Brief Summary
Obesity is a growing chronic medical condition in which as of 2015, a total of 107.7 million children and 603.7 million adults were considered obese and since 1980 the prevalence of obesity has double...
Detailed Description
Participants will be recruited through multiple medical clinics and will visit the exercise, nutrition and muscle metabolism lab twice over the course of 8-12 weeks to complete objective and subjectiv...
Eligibility Criteria
Inclusion
- Weight has not deviated by greater than 5 percent for 3 months
- Have excess grade skin of greater or equal to 2
- Percent total weight loss pre-body contouring of greater or equal to 25 percent
- Fluently read and write English
Exclusion
- Any musculoskeletal issues that would prevent participants from doing the physical function tests.
- Current medication history indicating atypical antipsychotics including but not limited to clozapine, olanzapine, quetiapine, risperidone, aripiprazole, amisulpride, ziprasidone, asenapine, iloperidone, lurasidone and paliperidone.
- Severe pulmonary conditions such as severe chronic obstructive pulmonary disease (COPD) and or severe asthma.
- Participants who actively aiming to lose weight
- Have diabetes with diabetic neuropathy or experienced hypoglycemic event within 6 months prior to the study
- Severe kidney disease with estimated glomerular filtration rate (eGFR) less than 60 ml/min
- Pregnant individuals
- Uncontrolled hypertension with resting blood pressure greater than 160/90 mmHg
- Uncontrolled obstructive sleep apnea with symptoms
- On statin therapy with myopathy
- Unstable atrial fibrillation
- Weight pre-body contouring greater than 340 lbs (154 kg)
- Current smoker
Key Trial Info
Start Date :
August 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 29 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04516473
Start Date
August 18 2020
End Date
December 29 2021
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia
Vancouver, British Columbia, Canada, V6T 1Z3